Should I Buy 01801? 01801 2026 Analysis

Should You Buy INNOVENT BIO (01801) Today? Analysis, Price Targets, and 2026 Outlook.

No data

Growth

Profitability

Efficiency

0 Analyst Rating

Wall Street analysts forecast 01801 stock price to rise

0 Buy

0 Hold

0 Sell

Current: 87.750

Low

Averages

High

Current: 87.750

Low

Averages

High

CMBI

Buy

maintain

AI Analysis

2026-03-31

Reason

CMBI

Price Target

AI Analysis

2026-03-31

maintain

Buy

Reason

CMBI maintains a 'Buy' rating on INNOVENT BIO due to its strong performance in fiscal year 2025, where it achieved its first full-year net profit of RMB834 million and a total revenue increase of 38%. The company's strong product line innovation capabilities and potential for global development support its transformation into a global biopharmaceutical company, leading to a slight increase in the target price from HKD110.62 to HKD113.86.

UBS

Buy

downgrade

$124

2026-03-27

Reason

UBS

Price Target

$124

2026-03-27

downgrade

Buy

Reason

UBS has lowered its target price for INNOVENT BIO due to a net loss in the second half of 2025, which was below expectations, despite a significant revenue growth. However, the overall annual performance showed a strong revenue increase and a return to profitability, leading UBS to maintain a 'Buy' rating.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for 01801

Unlock Now

01801 Should I Buy

01801 Should I Buy

Should You Buy INNOVENT BIO (01801) Today? Analysis, Price Targets, and 2026 Outlook.

No data

No data

Growth

Profitability

Efficiency

People Also Watch